Evora Biosciences
Amanda Silva Brun is a scientific board member at Région Île-de-France, bringing expertise in Innovation and Biotherapy. Amanda is the co-founder of Evora Biosciences and EVerZom, both since September 2020 and March 2020 respectively. With a background at CNRS as Director of Research since 2022, Amanda has been involved in research since 2013. Additionally, Amanda is an SFNano honorary member since 2023, with previous roles as Vice-President from 2021 to 2022 and board member since 2013 at SOCIETE FRANCAISE DE NANOMEDECINE.
This person is not in the org chart
This person is not in any teams
Evora Biosciences
Evora Biosciences is a preclinical biotech, developing novel anti-inflammatory cell penetrating peptides with the aim to bring first-in-class treatments to patients.